Matching geography

Reports matching your search in:
 
 

Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!
Region: All Regions > Africa
Category: All Categories > Life Sciences > Healthcare
(116 reports matching your criteria)
 
< prev 1  2  3  4  5  next >
Zambia Pharmaceuticals and Healthcare Report Q1 2013
1/16/2013 | published by: Business Monitor International
... by both NGOs and international investors as a sign that Zambia istaking its commitment to healthcare seriously. The country suffers from a burden of both communicableand non-communicable diseases, with a high incidence of HIV and ...  |  more...
$1,175.00
Morocco Pharmaceuticals and Healthcare Report Q1 2013
1/16/2013 | published by: Business Monitor International
... the evidence ofbribery and corruption, and the shortage of doctors in the sector. BMI believes the commitment toimprove governance and implement controls in the sector will be fulfilled in the medium-to-long term. Assuch, we maintain ...  |  more...
$1,175.00
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q1 2013
1/2/2013 | published by: Business Monitor International
... non-oil economies. Political risk remains elevated as many disputesbetween them are still unresolved. These macroeconomic uncertainties will mean lack of focus on publichealthcare provision, which further complicates the problem that the general population are unable ...  |  more...
$1,175.00
Gabon Pharmaceuticals and Healthcare Report Q1 2013
1/2/2013 | published by: Business Monitor International
... and the vast majority of expenditure will be on low-marginessential medicines. Due to tepid economic growth, our outlook for Gabon's pharmaceutical market isbelow that expected to be posted by many of its sub-Saharan Africa neighbours. ...  |  more...
$1,175.00
Healthcare, Regulatory and Reimbursement Landscape - South Africa
12/28/2012 | published by: GlobalData
... the South African healthcare, regulatory and reimbursement landscape, this report identifies the key trends in the healthcare market, as well as providing insights on the demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, ...  |  more...
$1,995.00
Botswana Pharmaceuticals and Healthcare Report Q1 2013
12/26/2012 | published by: Business Monitor International
... and healthcare companies, it is unlikely that the gap inhealthcare provision will be filled by private healthcare firms. We continue to maintain that given therelatively small pharmaceutical and healthcare market in Botswana, we do not ...  |  more...
$1,175.00
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q1 2013
12/26/2012 | published by: Business Monitor International
... Cuban pharmaceutical firms revealing plans to set upplants in the country. But private investment is the exception, rather than the rule, in the country, withCôte d'Ivoire depending upon historical ties with France, Morocco and Tunisia ...  |  more...
$1,175.00
Cameroon Pharmaceuticals and Healthcare Report Q1 2013
12/12/2012 | published by: Business Monitor International
... the overall low pharmaceutical expenditure. Thesituation is further complicated by poor intellectual property protection, slow approval processes andrampant corruption. Consequently we do not expect the market to be of significant interest tomultinational pharmaceutical firms. Headline ...  |  more...
$1,175.00
Tanzania Pharmaceuticals and Healthcare Report Q1 2013
12/12/2012 | published by: Business Monitor International
... increase. However, we are concerned by the continued reliance onforeign grants and concessional loans. Headline Expenditure Projections Pharmaceuticals: TZS340.1bn (US$214mn) in 2011 to an expected TZS406.0bn(US$257mn) in 2012; +19.4% growth in local currency terms and ...  |  more...
$1,175.00
Angola Pharmaceuticals and Healthcare Report Q1 2013
12/12/2012 | published by: Business Monitor International
... investors, Dos Santos’ re-election will ensure political stabilityand continuity. Consequently a ‘business-as-usual’ attitude exists. The election results have not alteredour market forecasts for Angola’s healthcare and pharmaceutical market. While we expect that there willbe an ...  |  more...
$1,175.00
Uganda Pharmaceuticals and Healthcare Report Q1 2013
12/12/2012 | published by: Business Monitor International
... both the rewards and the risks present ina market. With regards to assessing risks in the Ugandan healthcare sector, we have identified industryspecific dangers (such as low per-capita spending and poor access to healthcare facilities) ...  |  more...
$1,175.00
Healthcare, Regulatory and Reimbursement Landscape - Morocco
11/30/2012 | published by: GlobalData
... healthcare, regulatory and reimbursement landscape, this report identifies the key trends in the Morocco healthcare market, as well as providing insights on the demographic, regulatory, and reimbursement landscape, and the healthcare infrastructure of Morocco. Most ...  |  more...
$1,995.00
South Africa Pharmaceuticals and Healthcare Report Q4 2012
11/14/2012 | published by: Business Monitor International
... deep segregation betweenprivate and public healthcare facilities continues to leave the vast majority of the population withoutmedical care. BMI believes this will be rectified through the creation of the National Health Insurancescheme over the next ...  |  more...
$995.00
Herbal/Traditional Products in Egypt
11/2/2012 | published by: Euromonitor International
... trend was linked to the emergence of a larger mid-income group in the country and also to growing media coverage of the dangers of contaminated or poor quality herbs. Consequently, sales continued to see strong ...  |  more...
$900.00
Ghana Pharmaceuticals and Healthcare Report Q4 2012
10/17/2012 | published by: Business Monitor International
... donations and foreign aid to provide some of the medical services and treatments willcontinue to negatively impact the development of the local drug manufacturing industry. We expect thissituation to continue until the government makes substantial ...  |  more...
$1,175.00
West and Central Africa Pharmaceuticals and Healthcare Report Q4 2012
10/10/2012 | published by: Business Monitor International
... enjoying above-trend real GDP growth for thenext several years as new oil production and a set of major new investments give a temporary boost to theeconomy. However, the government has limited funds to make the ...  |  more...
$1,175.00
South Africa Healthcare IT Market Outlook to 2018 – Clinical IT Systems and Medical Imaging Information Systems
9/30/2012 | published by: GlobalData
... Imaging Information Systems” provides key market data on the South Africa Healthcare IT market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market ...  |  more...
$2,500.00
Middle East and Africa and South and Central America Healthcare IT Market Outlook to 2018 - Clinical IT Systems and Medical Imaging Information Systems
9/30/2012 | published by: GlobalData
... Central America Healthcare IT Market Outlook to 2018 - Clinical IT Systems and Medical Imaging Information Systems” provides key market data on the Middle East and Africa and South and Central America Healthcare IT market ...  |  more...
$3,500.00
Clinical IT Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
9/30/2012 | published by: GlobalData
... key market data on the Clinical IT Systems market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within seven market categories – ...  |  more...
$2,500.00
East Africa Pharmaceuticals and Healthcare Report Q4 2012
9/26/2012 | published by: Business Monitor International
... globally from a multinational involvement perspective. Oman’s RRR score, which provides an indication of the relative attractiveness of the pharmaceuticalmarket, has been unchanged from Q312 to Q412 at 50.2 out of 100. As a result ...  |  more...
$1,175.00
Nigeria Pharmaceuticals and Healthcare Report Q4 2012
9/26/2012 | published by: Business Monitor International
... a risky invitation to multinationals. Positivedevelopments, including foreign investment by Indian pharmaceutical companies and local drugmakersgetting closer to WHO prequalification, will increase the long-term attractiveness of the market.However, supply chain issues and local tendency to ...  |  more...
$1,175.00
Uganda Pharmaceuticals and Healthcare Report Q4 2012
9/26/2012 | published by: Business Monitor International
... indicators in the past ten years in its 5th UgandaDemographic and Health Survey report of 2011. The survey has found progress in several health sectorindicators, including fertility, maternal and child health, nutrition status, fertility rate, ...  |  more...
$1,175.00
Southern Africa Pharmaceuticals and Healthcare Report Q4 2012
9/19/2012 | published by: Business Monitor International
... to have high rewards and low risks for investors.The only country in Africa as promising as countries in the Middle East is South Africa. The Northernand Southern regions of Africa will gradually gain more interest ...  |  more...
$1,175.00
Zimbabwe Pharmaceuticals and Healthcare Report Q4 2012
9/19/2012 | published by: Business Monitor International
... of demand continues to be met through foreigndonations, indicating the dire situation in the country. At the same time, the domestic industry continuesto struggle, without much hope for government finances or credit extensions, which will ...  |  more...
$1,175.00
Herbal/Traditional Products in Kenya
9/13/2012 | published by: Euromonitor International
... consumer health. Furthermore, this category’s growth has overtaken that of local remedies due to the looming uncertainty concerning the latter’s products’ authenticity, given that this category – despite efforts to regulate it by the Pharmacy ...  |  more...
$900.00
< prev 1  2  3  4  5  next >